RxDoctor Payments Data

Jeffrey Aroesty, MD

Otolaryngology · Mount Arlington, NJNPI 1780633131

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (51.2%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Aerin Medical Inc. at 47.8% of the total. Reporting peaked in 2022 at $1,925 and has fallen 56.5% since, to $836 in 2025. Among otolaryngology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,710in general payments, 2019–2025

Across 170 payments — averaging $33.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aerin Medical Inc.$3K
  • Optinose US, Inc.$590
  • Sanofi$437
  • Welch Allyn$394
  • GSK$329
  • Regeneron Healthcare Solutions, Inc.$280
  • plus $954 from 18 others
$17,650in research payments, 2019–2025

Across 7 payments — averaging $2521.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Aerin Medical Inc.$18K

What the payments were for

  • Consulting fees$1,50026%
  • Speaking & faculty fees$75013%
  • Food & beverage$2,92551%
  • Education$1422%
  • Other$3947%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,710 in reported general payments places this provider in the 90th percentile of 232 otolaryngology providers in New Jersey.

See all otolaryngology providers in New Jersey

Medicare billing

Part B allowed, 2024
$207,924
Medicare patients
377
Services billed
2,451

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab12$44,905
Dexlansoprazole DrDexlansoprazole13$2,723
Fluticasone Propionate97$1,409
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth12$1,150
Montelukast Sodium52$917
Ipratropium Bromide23$621
Amitriptyline Hcl36$504
Azelastine Hcl17$494
Esomeprazole Magnesium12$397
Pantoprazole Sodium39$378
Omeprazole20$272
Azithromycin14$123
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav14$105

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Mount Arlington

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →